Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide Intrapolyp Injection in CRSwNP
NCT05474924Phase 4Unknown
- Sponsor
- Kafrelsheikh University
- Start
- Aug 2022
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of budesonide in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Kafrelsheikh University. Status: unknown.
02
Drugs
budesonide
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05474924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05474924.